← All trials
NCT04774809
Phase 2/Phase 3Interventional
Trials that are a combination of phases 2 and 3.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Jan 29, 2020
- Primary completion
- Feb 27, 2024
- Completion date
- Aug 10, 2024
- First posted
- Mar 1, 2021
- Last posted
- Apr 8, 2021
- Enrollment
- 300
- Arms / groups
- 3 / —
- Source
- AACT · ingestion pipeline
Sponsors
- Reistone Biopharma Company LimitedLead sponsor
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.